Intas Pharmaceuticals Limited Ondansetron Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Ondansetron Export Records India — #12 Exporter, 511 Shipments, $2.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ondansetron

India Pharmaceutical Trade Intelligence

$121.0M537 Suppliers157 CountriesHS 30049035

ExportsIndia → UNITED STATES58.8%India → AUSTRALIA6.0%

ImportsUNITED STATES → India$21.1K UNITED KINGDOM → India$14.4K

#1 Buyer: GLENMARK PHARMACEUTICALS

Intas Pharmaceuticals Limited — Ondansetron Exporter #12 | $2.5M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Ondansetron Exporter Profile

Indian Pharmaceutical Exporter · #12 for Ondansetron · $2.5M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #12 Indian exporter of Ondansetron with $2.5M in export value and 511 verified shipments. Intas Pharmaceuticals Limited holds a 2.1% market share in Ondansetron exports across 15 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Ondansetron Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Ondansetron export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Ondansetron?

Country	Value	Shipments	Share
MEXICO	$593.7K	68	24.6%
UNITED STATES	$429.5K	15	17.8%
NETHERLANDS	$314.2K	75	13.0%
ITALY	$181.2K	110	7.5%
POLAND	$160.7K	32

Who Are the Top Buyers of Ondansetron from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$417.3K	14
TO THE ORDER	UNITED KINGDOM	$231.0K	54
ACCORD FARMA S.A. DE C.V.	MEXICO	$172.3K	18
ACCORD FARMA S.A.DE C.V	MEXICO	$144.8K	22
ACCORD UK	UNITED KINGDOM	$132.1K	14
ACCORD FARMA S A DE C V	MEXICO	$131.1K	5
ACCORD HEALTHCARE PTE LTD	SINGAPORE	$106.6K	7
ALLOGA FRANCE	FRANCE	$96.7K	7
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$88.5K	11
ACCORD HEALTHCARE ITALIA SRL	ITALY	$82.8K	10

Intas Pharmaceuticals Limited supplies Ondansetron to 51 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by TO THE ORDER (UNITED KINGDOM) and ACCORD FARMA S.A. DE C.V. (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ondansetron Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI ONDANSETRON INJ USP	$256.7K	9
PHARMA DRUGS & MEDI ONDANSETRON BLS,2MG/	$129.6K	22
PH.DRU.& MED. HT-BLOC 8MG/4ML INJ. - 3 AMPOULES EACH ML CONTAINS: ONDANSETRON HYDROCHLORIDE DIHYDRATE PH.EUR EQ.TO	$122.1K	6
PHR DRUGS & MEDI ONDANSETRON INJ USP 2MG	$84.2K	3
PHR DRUGS&MEDI ONDANSETRON INJ USP 2MG/M	$76.4K	2
PHARMA DRUGS & MEDI ONDANSETRON ACCORD 4MG/2ML 2X5A AUS AS PER INVOICEVLS	$64.7K	5
PHARMA DRUGS & MEDI ONDANSETRON BLS2MG/M	$58.6K	4
PHARMA.DRUGS & MEDICINE HT-BLOC 4MG/2MLINJ-1 AMPOULES EACH ML CONT.ONDANSETRONHYDROCHLORIDE DIHYDRATE PH.EUR EQ.TO ONDVLS	$58.6K	3
PHARMA DRUGS AND MEDI HT-BLOC 8MG/4ML INJ. - 3 AMPOULES EACH ML CONTAINS: ONDANSETRON HYDROCHLORIDE DIHYDRATE PH.EUR EQ.	$58.3K	3
PHARMA DRUGS AND MEDI HT-BLOC 8MG/4ML INJ.-3 AMPOULES EACH ML CONTAINS: ONDANSETRON 2MG WATER FOR INJECTION PH.EUR	$50.0K	1

Intas Pharmaceuticals Limited exports 279 distinct Ondansetron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI ONDANSETRON INJ USP with 9 shipments worth $256.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Ondansetron Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	CIPLA LIMITED	$3.0M	204	7	$14.5K
11	IPCA LABORATORIES LIMITED	$2.8M	80	3	$35.4K
12	INTAS PHARMACEUTICALS LIMITED ★	$2.5M	511	15	$4.9K
13	DR REDDYS LABORATORIES LIMITED	$1.9M	58	3	$33.4K
14	NATCO PHARMA LIMITED	$1.6M	90	3	$18.0K

Intas Pharmaceuticals Limited ranks #12 among 537 Indian Ondansetron exporters. Average shipment value of $4.9K compared to the market average of $186.5K. The closest competitors by value are CIPLA LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Ondansetron Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,058	12.5%
NHAVA SHEVA SEA (INNSA1)	1,026	12.1%
SAHAR AIR	993	11.7%
HYDERABAD ICD (INSNF6)	509	6.0%
HYDERABAD ICD	448	5.3%
JNPT/ NHAVA SHEVA SEA	343	4.1%
DELHI AIR CARGO ACC (INDEL4)	265	3.1%
AHEMDABAD AIR ACC (INAMD4)	224	2.6%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ondansetron Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 517 individual customs records matching Intas Pharmaceuticals Limited exporting Ondansetron, covering 279 formulations to 15 countries via 51 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 157+ countries, 1,636+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ondansetron

Ondansetron

Intas Pharmaceuticals Limited — Ondansetron Exporter Profile

Intas Pharmaceuticals Limited — Ondansetron Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Ondansetron?

Who Are the Top Buyers of Ondansetron from Intas Pharmaceuticals Limited?

What Is India's Total Ondansetron Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Ondansetron Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Ondansetron Exporters?

What Ondansetron Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Ondansetron to Key Markets

Mexico — COFEPRIS

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Ondansetron Exporters?

Which Indian Ports Ship Ondansetron Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ondansetron Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ondansetron Export Data from Intas Pharmaceuticals Limited

Ondansetron Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source